Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer

Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer

Background: Stromelysins are potential breast cancer biomarkers. The aim of the study was to evaluate if plasma levels of selected metalloproteinases (MMPs) (stromelysin-1 (MMP-3) and stromelysin-10 (MMP-10)) and cancer antigen 15-3 (CA 15-3) used separately and in combination demonstrated diagnosti...

Full description

Bibliographic Details
Main Authors: Barbara Maria Piskór, Andrzej Przylipiak, Emilia Dąbrowska, Iwona Sidorkiewicz, Marek Niczyporuk, Maciej Szmitkowski, Sławomir Ławicki
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Journal of Clinical Medicine
Subjects:
stromelysins
MMP-3
MMP-10
plasma concentration
Online Access:https://www.mdpi.com/2077-0383/9/12/4122

Internet

https://www.mdpi.com/2077-0383/9/12/4122

Similar Items